Curis Lifesciences
Curis Lifesciences Share Price Chart
Curis Lifesciences last traded at ₹191.90 (2026-10-13). Over the past month the stock moved -8.1%, three months the stock moved +57.3%. Its closing range over 52 weeks is ₹88.80 – ₹230.10, with the latest close 16.6% below the high.
Closing prices up to 2026-10-13.
About Curis Lifesciences
Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products.[1]
Business Overview:[1][2] CLSL is a WHO-GMP certified pharma company based in Ahmedabad, India. The co. provides healthcare solutions with loan licensing and also contract manufacturing and offers pharma products formulated from solid and liquid forms to deliver adherence to every therapeutic category. Its offerings also include sterile and non-sterile products. The company exports to 10+ countries and has 18k+ customers
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 32.72 | 5.14 | 15.71 | 2.71 | 3.35 |
| Sep 2025 | 27.91 | 5.99 | 21.46 | 4.21 | 7.09 |
| Mar 2025 | 34.36 | 6.93 | 20.17 | 4.00 | 6.74 |
| Sep 2024 | 15.90 | 3.81 | 23.96 | 2.20 | 44.00 |
Annual Financials
In the latest year (Mar 2026), Curis Lifesciences reported sales of ₹60.63 crore (+23.4%) and net profit of ₹6.92 crore (+13.3%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 60.63 | 11.13 | 18.36 | 6.92 | 8.56 |
| Mar 2025 | 49.13 | 9.54 | 19.42 | 6.11 | 10.30 |
| Mar 2024 | 35.58 | 8.44 | 23.72 | 5.36 | 107.20 |
| Mar 2023 | 35.42 | 3.26 | 9.20 | 1.23 | 24.60 |
| Mar 2022 | 23.70 | 3.58 | 15.11 | 0.49 | 9.80 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | +49.5% | +0.5% | +38.1% | +23.4% |
| Operating profit growth | -8.9% | +158.9% | +13.0% | +16.7% |
| Net profit growth | +151.0% | +335.8% | +14.0% | +13.3% |
| EPS growth | +151.0% | +335.8% | -90.4% | -16.9% |
| OPM % | 9.2% | 23.7% | 19.4% | 18.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Curis Lifesciences.
Get Free AI Stock Analysis FREE →Latest News
-
Curis Lifesciences FY26 net profit rises 11.4% to ₹691.63 lakh - scanx.trade
-
Curis Lifesciences FY26 net profit rises 11.4% to ₹691.63 lakh - scanx.trade
-
Curis Lifesciences FY26 net profit rises 11.4% to ₹691.63 lakh - scanx.trade
Frequently Asked Questions
What is Curis Lifesciences's current stock price?
Curis Lifesciences shares were last quoted at ₹191.90 (-5.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Curis Lifesciences?
Curis Lifesciences has a price-to-earnings (P/E) ratio of 26.13 and a price-to-book (P/B) ratio of 3.82. The industry P/E is 53.33.
What is the 52-week high and low of Curis Lifesciences?
The 52-week high of Curis Lifesciences is ₹228.80 and the 52-week low is ₹83.60.
What is the market cap of Curis Lifesciences?
The market capitalisation of Curis Lifesciences is about ₹180.81 crore.
Is Curis Lifesciences a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Curis Lifesciences has a 3-year ROE of 39.00%, 3-year profit growth of 78.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Curis Lifesciences?
Promoters hold about 68.03% of Curis Lifesciences.
Which sector does Curis Lifesciences belong to?
Curis Lifesciences belongs to the Pharmaceuticals & Drugs sector.